Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Yahoo! Finance
Net loss: US$13.5m (loss narrowed by 12% from 1Q 2023). US$0.45 loss per share (improved from US$0.52 loss in 1Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Fulgent Genetics EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 27%. Looking ahead, revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are up 4.5% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Fulgent Genetics' balance sheet. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- Moffitt and Fulgent Pharma partner on personalised cancer therapies [Yahoo! Finance]Yahoo! Finance
- Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics [Yahoo! Finance]Yahoo! Finance
- Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer TherapeuticsBusiness Wire
- Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain [Yahoo! Finance]Yahoo! Finance
- Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of PainPR Newswire
FLGT
Earnings
- 5/3/24 - Beat
FLGT
Sec Filings
- 5/16/24 - Form 8-K
- 5/7/24 - Form 4
- 5/7/24 - Form 4
- FLGT's page on the SEC website